Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 1 |
2016 | 1 |
2018 | 1 |
2019 | 2 |
2022 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2019 Dec;20(12):1655-1669. doi: 10.1016/S1470-2045(19)30634-5. Epub 2019 Oct 4.
Lancet Oncol. 2019.
PMID: 31591063
Clinical Trial.
Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.
Tankyevych O, Trousset F, Latappy C, Berraho M, Dutilh J, Tasu JP, Lamour C, Cheze Le Rest C.
Tankyevych O, et al. Among authors: lamour c.
Cancers (Basel). 2022 Nov 30;14(23):5931. doi: 10.3390/cancers14235931.
Cancers (Basel). 2022.
PMID: 36497415
Free PMC article.
Item in Clipboard
Targeted RNA-sequencing assays: a step forward compared to FISH and IHC techniques?
Tachon G, Cortes U, Richard S, Martin S, Milin S, Evrard C, Lamour C, Karayan-Tapon L.
Tachon G, et al. Among authors: lamour c.
Cancer Med. 2019 Dec;8(18):7556-7566. doi: 10.1002/cam4.2599. Epub 2019 Oct 25.
Cancer Med. 2019.
PMID: 31651105
Free PMC article.
Item in Clipboard
Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial.
Meyer G, Besse B, Doubre H, Charles-Nelson A, Aquilanti S, Izadifar A, Azarian R, Monnet I, Lamour C, Descourt R, Oliviero G, Taillade L, Chouaid C, Giraud F, Falcoz PE, Revel MP, Westeel V, Dixmier A, Tredaniel J, Dehette S, Decroisette C, Prevost A, Pichon E, Fabre E, Soria JC, Friard S, Stern JB, Jabot L, Dennewald G, Pavy G, Petitpretz P, Tourani JM, Alifano M, Chatellier G, Girard P.
Meyer G, et al. Among authors: lamour c.
Eur Respir J. 2018 Oct 4;52(4):1801220. doi: 10.1183/13993003.01220-2018. Print 2018 Oct.
Eur Respir J. 2018.
PMID: 30262574
Free article.
Clinical Trial.
Item in Clipboard
High-risk patients following hospitalisation for an acute exacerbation of COPD.
Piquet J, Chavaillon JM, David P, Martin F, Blanchon F, Roche N; French College of General Hospital Respiratory Physicians (CPHG).
Piquet J, et al.
Eur Respir J. 2013 Oct;42(4):946-55. doi: 10.1183/09031936.00180312. Epub 2013 Jan 24.
Eur Respir J. 2013.
PMID: 23349446
Free article.
Item in Clipboard
Real-life effectiveness of erlotinib as second-line treatment of stage IIIB/IV squamous non-small cell lung cancer: Results of the PEPiTA observational study.
Monnet I, Audigier-Valette C, Girard N, Vergnenègre A, Molinier O, Souquet PJ, Blanchon F, Bonnetain F, Taguieva-Pioger N, Lamour C, Wislez M.
Monnet I, et al. Among authors: lamour c.
Lung Cancer. 2016 Aug;98:84-90. doi: 10.1016/j.lungcan.2016.05.016. Epub 2016 May 26.
Lung Cancer. 2016.
PMID: 27393512
Item in Clipboard
Visual versus quantitative assessment of intratumor 18F-FDG PET uptake heterogeneity: prognostic value in non-small cell lung cancer.
Tixier F, Hatt M, Valla C, Fleury V, Lamour C, Ezzouhri S, Ingrand P, Perdrisot R, Visvikis D, Le Rest CC.
Tixier F, et al. Among authors: lamour c.
J Nucl Med. 2014 Aug;55(8):1235-41. doi: 10.2967/jnumed.113.133389. Epub 2014 Jun 5.
J Nucl Med. 2014.
PMID: 24904113
Free article.
Item in Clipboard
Cite
Cite